Comprehensive SRS Replacement: This system consist of a proximal humeral replacement, distal humeral replacement, or total humeral replacement.
Study summary
Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Non Inflammatory Degenerative joint disease, including osteoarthritis, and avascular necrosis
* Rheumatoid arthritis
* Revision where other devices or treatments have failed
* Correction of functional deformity
* Oncology applications including bone loss due to tumour resection
Exclusion Criteria:
* Sepsis ( active)
* Infection ( active)
* Osteomyelitis (active)
Primary outcome measure(s)
Implant survivorship assessed according to the implant revisions — 10 years Implant survivorship assessed counting the number of implant revisions
Trial sites (4)
Facility
City
Region
Status
Nova Scotia Health Authority
Halifax
Nova Scotia
Department of Orthopedic Surgery, Rigshospitalet University of Copenhagen
Copenhagen
Denmark
Royal Gwent Hospital
Newport
Wales
Royal Liverpool University Hospital
Liverpool
United Kingdom
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.